A patient diagnosed with depression begins selective serotonin reuptake inhibitor (SSRI) antidepressant therapy. The nurse should provide information to the patient and family about which of the following?

Choice A reason: When initiating SSRI therapy, there is a documented risk of increased suicidality, especially in children, adolescents, and young adults. As the medication begins to take effect, patients may regain enough physical energy to act on suicidal ideations before their mood significantly improves, necessitating close monitoring by family and clinicians. Choice B reason: A tyramine-free diet is specifically required for patients taking Monoamine Oxidase Inhibitors (MAOIs), not SSRIs. Consuming high-tyramine foods like aged cheese or red wine while on MAOIs can trigger a hypertensive crisis. SSRIs do not interact with tyramine, so this dietary restriction is clinically unnecessary for this patient. Choice C reason: Minimizing exposure to bright sunlight is a precaution typically associated with photosensitizing medications, such as certain antipsychotics (e.g., Chlorpromazine) or tetracycline antibiotics. While some patients may experience mild skin sensitivity, it is not a primary or priority teaching point for the standard administration of SSRI antidepressants. Choice D reason: Restricting sodium intake to 1 gram daily is not indicated for SSRI therapy. In fact, SSRIs are occasionally associated with hyponatremia (low sodium levels), particularly in elderly patients, due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Therefore, aggressive sodium restriction could actually be counterproductive and dangerous.